Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-00915275 4-week safety, tolerability, PK and PD study in type 2 diabetes mellitus
2006-006768-53Phase 2Completed
- Sponsor
- Pfizer
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) comparing PF-00915275 10 mg with Placebo (2 arms). Primary endpoints: Pharmacokinetic endpoints, Safety and tolerability and 1 more. Started Jan 2007; status: completed.
02
Drugs
PF-00915275
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2006-006768-53.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006768-53.